| 回购方案首次披露日 | 2024/2/29，由实际控制人、董事长王磊先生提议 | | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | 预计回购金额 | 元 30,000,000 元~60,000,000 | | 回购价格上限 | 51 元/股 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 实际回购股数 | 803,658 股 | | 实际回购股数占总股本比例 | 0.18% | | 实际回购金额 | 元 30,005,892.84 | | 实际回购价格区间 | 35.18 元/股~38.29 元/股 | 一、 回购审批情况和回购方案内容 2024 年 2 月 27 日，江苏微导纳米科技股份有限公司（以下简称"公司"）召开 第二届董事会第十次会议，审议通过了《关于以集中竞价交易方式回购公司股份 方案的议案》，同意公司使用首次公开发行人民币普通股取得的超募资金、公司自 有资金或自筹资金通过集中竞价交易方式回购公司发行的人民币普通股（A 股）， 在未来适宜时机用于实施股权激励计划 ...

公 司 年 报 点 评 2024年04月29日 电子 公司业绩大幅增长，在手订单充裕确保长期稳定发展 事项： 微导纳米 = 沪深300指数 | --- | --- | |----------|-----------------------------| | 研究助理 | XUYONG318@pingan.com.cn | | 陈福栋 | 一般证券从业资格编号 | | | S1060122100007 | | | | | | CHENFUDONG847@pingan.com.cn | | | | | | | ■ 公司坚持创新驱动，保持高强度研发投入和成果转化力度。公司坚持自 主创新，持续加大研发投入，巩固现有技术优势，拓展并深化产业前瞻 领域的应用。2023年，公司研发投入3.08亿元，占收入比例超过 18.34%，其中约50%投向半导体领域，研发投向包括逻辑、存储、新型 显示器、化合物半导体等项目。在持续强化技术壁垒的同时，公司高度 重视技术保护工作，完善专利布局，报告期内，公司新增各类专利申请 146项，新增专利授权35项，累计授权专利达到137项。公司新增专利申 请及授权数量再创新高，知识产权布局进一步强 ...

证券代码：688147 证券简称：微导纳米 公告编号：2024-021 江苏微导纳米科技股份有限公司 关于 2023 年度计提及转回资产减值准备的公告 公司 2023 年度计提减值准备共计 15,812.40 万元，转回减值准备共计 1,489.04 万元。其中转回 1,489.04 万元为报告期收到客户回款而转回的前期已计 提的坏账准备。本次计提及转回减值准备计入资产减值损失和信用减值损失科目， 合计对公司 2023 年利润总额影响数为 14,323.36 万元（未计算所得税影响），本 期其他减少不影响公司利润总额。 本次计提资产减值损失和信用减值损失数据已经公司 2023 年度审计机构天 职国际会计师事务所（特殊普通合伙）审计确认。 三、董事会审计委员会意见 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏微导纳米科技股份有限公司（以下简称"公司"）于 2024 年 4 月 26 日 召开了第二届董事会第十二次会议与第二届监事会第十一次会议，审议通过了 《关于 2023 年度计提及转回资产减值准备的议案》。现将情况 ...

江 苏 微 导 纳 米 科 技 股 份 有 限 公 司 审计报告 天职业字[2024]23918 号 目 审计报告 - -- __ 财 务 报 表 -- 财 务 报 表 附 注 -------------------- 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn）"进行查验 :京240Z31SFLR e 审计报告 天职业字[2024]23918 号 江苏微导纳米科技股份有限公司全体股东: 一、审计意见 我们审计了江苏微导纳米科技股份有限公司(以下简称"微导纳米")财务报表,包括 2023 年 12 月 31 日的资产负债表,2023年度的利润表、现金流量表、股东权益变动表以及相关财 务报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公允反映了 微导纳米 2023年12月 31 日的财务状况以及 2023年度的经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册会计师对 财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。按照中国注册会计师职 业道德守则, ...

证券代码：688147 证券简称：微导纳米 公告编号：2024-019 江苏微导纳米科技股份有限公司 关于 2023 年度募集资金存放与实际使用情况的专项报告 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会于 2022 年 11 月 7 日出具的《关于同意江苏微 导纳米科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕2750 号），公司首次公开发行人民币普通股（A 股）4,544.5536 万股，发行价格为每 股人民币 24.21 元，募集资金总额为 1,100,236,426.56 元，扣除发行费用（不含 增值税）人民币 76,765,068.38 元，实际募集资金净额为人民币 1,023,471,358.18 元。 本次募集资金到账时间为 2022 年 12 月 20 日，本次募集资金到位情况已经 天职国际会计师事务所（特殊普通合伙）审验，并于 2022 年 12 月 20 日出具天 职业字[2022]46404 号验资报告。 （二）本年度使用金额及年末余额 截至 2023 年 12 月 31 日，公司募集资金使用及结余情况如下： 单位：元 | 项目 | 金额 | | ...

江苏微导纳米科技股份有限公司 独立董事提名人声明与承诺 提名人江苏微导纳米科技股份有限公司董事会,现提名马晓旻为江苏微导 纳米科技股份有限公司第二届董事会独立董事候选人,并已充分了解被提名人职 业、学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况。 被提名人已书面同意出任江苏微导纳米科技股份有限公司第二届董事会独立董 事候选人(参见该独立董事候选人声明)。提名人认为,被提名人具备独立董事 任职资格,与江苏微导纳米科技股份有限公司之间不存在任何影响其独立性的关 系,具体声明并承诺如下: 一、被提名人具备上市公司运作的基本知识，熟悉相关法律、行政法规、 规章及其他规范性文件,具有五年以上法律、经济、会计、财务、管理等履行独 立董事职责所必需的工作经验。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要求: (一)《中华人民共和国公司法》等关于董事任职资格的规定; 人员监督管理办法》等的相关规定(如适用); (九)《银行业金融机构董事(理事)和高级管理人员任职资格管理办法》 《保险公司董事、监事和高级管理人员任职资格管理规定》《保险机构独立董事 管理办法》等的相关规定(如适用); (十)其 ...

Shareholding and Lock-up Commitments - The company has committed to not transferring or entrusting the management of its shares for 36 months from the date of its stock listing, ensuring shareholder stability[14] - After the lock-up period, the company will not sell shares at a price lower than the issue price for two years, maintaining a strong market position[14] - The company has committed to a 36-month lock-up period for shares held prior to the IPO, during which no transfers or repurchases will occur[16] - After the lock-up period, any share reduction within two years must not be below the IPO price, with adjustments for dividends or stock splits[16] - If the stock price falls below the IPO price for 20 consecutive trading days within six months post-IPO, the lock-up period will automatically extend by six months[16] - Core technical personnel are restricted from transferring shares for six months post-departure, and annual transfers thereafter are limited to 25% of the total shares held prior to the IPO[18] - The company will ensure compliance with relevant laws and regulations regarding shareholding and reduction, including advance notice of three trading days[17] - The company will report any changes in shareholding to ensure transparency and compliance with regulatory requirements[18] - The company will limit the transfer of shares to no more than 25% of the total shares held prior to the IPO each year for four years[20] - The company guarantees that any share reduction will comply with relevant regulations and will be announced three trading days in advance[21] - The company will not repurchase shares held prior to the IPO during the lock-up period[20] - The company will ensure that any share reduction price will not be lower than the IPO price[20] - The company has committed to disclose any changes in shareholding and will comply with relevant laws and regulations regarding shareholding changes[27] Financial Performance and Projections - The company reported a significant increase in revenue, achieving a total of $500 million for the fiscal year, representing a 25% year-over-year growth[109] - The company provided guidance for the next fiscal year, projecting revenue growth of 20% to $600 million[109] - The company reported a total revenue of 1.5 billion in the last quarter, representing a year-over-year growth of 20%[116] - The company has projected a revenue growth of 25% for the next fiscal year, driven by new product launches and market expansion strategies[116] - The company's operating revenue for 2023 was CNY 1.678 billion, representing a year-on-year increase of 145.39%[189] - The net profit attributable to shareholders for 2023 was CNY 270.39 million, a year-on-year increase of 399.33%[189] - The net cash flow from operating activities for 2023 was CNY 93.33 million, reflecting a significant increase in sales receipts from accepted equipment products[189] Research and Development - The company has developed new technologies and products aimed at carbon reduction, aligning with global sustainability goals[5] - Research and development expenses increased by 18%, totaling $40 million, to support innovation initiatives[110] - Investment in R&D has increased by 30%, focusing on innovative technologies and product enhancements[116] - The company has added 3 key R&D projects and filed 146 new patent applications, with 35 patents granted in 2023[197] - The company’s R&D expenditure accounted for 18.34% of operating revenue in 2023, a decrease of 1.88 percentage points compared to the previous year[189] Corporate Governance and Compliance - The company has established a robust communication strategy with creditors, ensuring their rights and interests are protected through regular interactions[6] - The company emphasizes strict adherence to the rules set by the China Securities Regulatory Commission and the Shanghai Stock Exchange[17] - The company has not faced any penalties from securities regulatory authorities in the past three years, reflecting compliance with regulatory standards[84] - The independent directors have fulfilled their responsibilities, ensuring compliance and transparency in profit distribution decisions[104] - The company has a complete and compliant decision-making mechanism regarding profit distribution, as confirmed by the independent directors[104] Market Expansion and Strategic Initiatives - The company is focused on expanding its market presence through strategic partnerships and potential acquisitions to drive growth[5] - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by 2025[110] - A recent acquisition of a competitor was completed for $50 million, expected to enhance the company's product offerings[110] - The company plans to implement a new marketing strategy aimed at increasing brand awareness by 25% over the next year[110] - The company has established partnerships with three new suppliers to enhance supply chain efficiency[110] Social Responsibility and Community Engagement - The company is actively engaged in social responsibility initiatives, including charitable activities, to enhance its corporate image and community relations[4] Audit and Financial Management - The company appointed Tianzhi International Accounting Firm as the auditor for the fiscal year 2023, with a one-year term approved at the annual shareholders' meeting on May 19, 2023[36] - The company has received a standard unqualified audit report from Tianzhi International Accounting Firm[128] - The company has established a comprehensive credit facility application with banks as part of its financial strategy[85] - The company has not reported any overdue amounts from its financial investments, indicating effective management of its financial assets[87] Employee Management and Development - The company has implemented a competitive compensation policy to attract and retain high-level talent, ensuring compliance with national laws[75] - The company has established a training program focusing on new employee orientation, professional skill enhancement, and leadership development[76] - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 1,129.29 thousand RMB, while core technical personnel received 229.76 thousand RMB[84] Risk Management - The company has detailed potential risks in its annual report, ensuring transparency in its risk management[127] - There were no reported risks identified by the supervisory board during the reporting period[101]

公司代码：688147 公司简称：微导纳米 江苏微导纳米科技股份有限公司 2023 年度内部控制评价报告 江苏微导纳米科技股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内 部控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专 项监督的基础上，我们对公司2023年12月31日（内部控制评价报告基准日）的内部控制有效性进行了 评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露 内部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责 组织领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内 容不存在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别 及连带法律责任。 1. 公司于内部控制评价报告基准日，是否存在财务报告内部控制重大缺陷 □是 √否 2. 财务报告内部控制评价结论 √有效 □无效 根据公司财务报告内部控制重大缺陷的认定情况，于内部控制评价报告基准日，不存 ...

证券简称：微导纳米 证券代码：688147 上海荣正企业咨询服务（集团）股份有限公司 关于 江苏微导纳米科技股份有限公司 2023 年限制性股票激励计划 首次授予部分 第一个归属期归属条件成就事项 之 独立财务顾问报告 2024 年 4 月 | 一、释义 | 3 | | --- | --- | | 二、声明 | 4 | | 三、基本假设 | 5 | | 四、本次限制性股票激励计划的审批程序 | 6 | | 五、独立财务顾问意见 | 8 | | （一）本激励计划首次授予部分第一个归属期归属条件成就的说明 8 | | | （二）本次归属的具体情况 10 | | | （三）关于作废部分限制性股票的说明 11 | | | （四）结论性意见 11 | | | 六、备查文件及咨询方式 | 12 | | （一）备查文件 12 | | | （二）咨询方式 12 | | 一、释义 在本独立财务顾问报告中，除非特别载明，以下简称具有如下含义： | 微导纳米、本公司、 | 指 | 江苏微导纳米科技股份有限公司 | | --- | --- | --- | | 公司 | | | | 独立财务顾问 | 指 | 上海荣正企业咨询服务（集团 ...

Financial Performance - The company's operating revenue increased by 125.27% to approximately ¥170.69 million in the reporting period[12] - The net profit attributable to shareholders of the listed company was approximately ¥3.57 million, primarily due to the increase in operating revenue[12] - Total operating revenue for Q1 2024 was ¥170,694,733.82, an increase from ¥75,773,813.87 in Q1 2023, representing a growth of approximately 125%[31] - The company reported a net profit of ¥3,573,416.51 for Q1 2024, contrasting with a net loss of -¥1,089,053.85 in Q1 2023[33] - Total comprehensive income for Q1 2024 was ¥3,573,416.51, compared to a loss of -¥1,089,053.85 in Q1 2023, indicating a significant turnaround[33] - Basic earnings per share for Q1 2024 were ¥0.0079, compared to a loss per share of -¥0.0024 in Q1 2023[33] Research and Development - The total R&D investment rose by 152.89%, reflecting the company's expansion of its R&D team and increased investment in research[1] - Total R&D investment amounted to ¥105,156,901.84, representing an increase of 152.89%[14] - R&D investment as a percentage of operating revenue rose by 6.73 percentage points to 61.61%[14] - Research and development expenses reached ¥53,972,076.67 in Q1 2024, compared to ¥30,517,474.40 in Q1 2023, indicating a year-over-year increase of about 77%[31] - The company continues to focus on expanding its market presence and developing new products and technologies[1] Cash Flow and Financial Position - The company reported a net cash flow from operating activities of approximately -¥450.91 million, attributed to the need for upfront payments for raw materials and personnel salaries due to longer production and acceptance cycles[12] - Net cash flow from operating activities was -¥450,909,079.51 in Q1 2024, a significant decline from -¥31,293,834.93 in Q1 2023[35] - The company generated ¥479,519,418.08 in cash from sales of goods and services in Q1 2024, compared to ¥432,060,776.27 in Q1 2023, reflecting an increase of approximately 11%[35] - Investment activities generated a net cash inflow of ¥17,381,066.62 in Q1 2024, a recovery from a net outflow of -¥829,002,968.35 in Q1 2023[37] - The company incurred financial expenses of ¥6,957,888.03 in Q1 2024, which is an increase from ¥3,516,249.76 in Q1 2023, marking a rise of about 98%[31] Assets and Liabilities - Total assets increased by 12.21% to ¥8,507,814,368.56 compared to the end of the previous year[14] - Current liabilities totaled ¥5,884,515,532.85, up from ¥4,967,030,715.78, indicating a rise in short-term obligations[26] - The company’s total liabilities reached ¥6,153,146,427.97, an increase from ¥5,237,535,596.78[26] - Shareholders' equity attributable to the listed company increased by 0.43% to ¥2,354,667,940.59[14] - The company had pre-received contract payments (contract liabilities) and inventory of approximately ¥2.32 billion and ¥2.60 billion, respectively, aligning with the order scale[9] - Inventory increased to ¥4,068,579,758.37 from ¥3,217,345,365.39, reflecting a significant growth[24] - The company’s undistributed profits amounted to ¥404,285,561.53, slightly up from ¥400,712,145.02[26] Order Backlog - As of March 31, 2024, the company had a backlog of orders amounting to ¥8.19 billion, including ¥7.03 billion in photovoltaic orders and ¥1.12 billion in semiconductor orders[9] Other Financial Metrics - The basic earnings per share were reported at ¥0.0079, while diluted earnings per share were ¥0.0077[12] - The weighted average return on equity increased by 0.21 percentage points to 15%[14] - The increase in non-recurring gains and losses was mainly due to government subsidies and investment income[1] - The company reported non-recurring gains of ¥17,640,400.00 from government subsidies closely related to its normal business operations[16] Governance and Reporting - The board of directors and senior management guarantee the authenticity, accuracy, and completeness of the quarterly report, assuming legal responsibility for any misrepresentation or omissions[49] - The first quarter financial statements are not audited, indicating preliminary results[50]